vaping lung disease
Vaping-Related Lung Disease: Understanding the Risks and Chemical Differences
Vaping-related lung disease encompasses a spectrum of respiratory issues triggered by inhaling aerosolized chemicals. The most prominent acute condition is EVALI (E-cigarette or Vaping Use-Associated Lung Injury), but vaping is also linked to long-term risks like chronic bronchitis, asthma, and irreversible small airway scarring.
EVALI: A Severe Chemical Inhalation Injury
EVALI is a severe, acute chemical inhalation injury that gained national attention in 2019 and continues to be diagnosed in users of both THC and nicotine products. The primary trigger for EVALI is heavily associated with Vitamin E acetate, a thickening agent often found in illicit or informal THC vape cartridges. Symptoms of EVALI include shortness of breath, chest pain, cough, fever, nausea, and vomiting, which can develop over days or weeks. Treatment for EVALI involves stopping vape exposure entirely, and severe cases may require hospitalization, supplemental oxygen, or steroids to reduce inflammation.
Long-Term Pulmonary Risks
Even without acute conditions like EVALI, repeated inhalation of heavy metals, volatile organic compounds, and flavorings causes sustained inflammation. Long-term effects include lipoid pneumonia, bronchiolitis obliterans ("popcorn lung"), and chronic disease. Research indicates that e-cigarette users face an increased risk of developing asthma, emphysema, and COPD.
Chemical Differences Between THC and Nicotine Vaping
It is essential to acknowledge the fundamental chemistry difference between THC and nicotine vaping. THC formulations are oil-based, whereas commercial nicotine e-liquids are water-soluble. The base ingredients of nicotine vapes are vegetable glycerin (VG) and propylene glycol (PG), which are alcohols (polyols) that are completely miscible in water, not lipids. Conversely, THC is highly hydrophobic and requires oily solvents.
Reasons for Conflation in Research
Despite the stark chemical division, research often groups THC and nicotine vaping under the umbrella term "vaping-related lung disease" for several reasons:
- EVALI and the Vitamin E Acetate Conundrum: The 2019 outbreak of EVALI is where the conflation most frequently occurs. The primary driver of the acute outbreak was Vitamin E acetate, an oil-based thickening agent used exclusively in illicit THC cartridges.
- Overlapping Mechanics: Both THC and nicotine vape pens utilize heating elements, which can leach heavy metals into the inhaled aerosol. Superheating both PG/VG (nicotine bases) and carrier oils (THC bases) causes thermal degradation, creating toxic byproducts like acrolein, formaldehyde, and acetaldehyde.
- Divergent Long-Term Pathologies: Pulmonologists study the two types of vaping differently because their chemical bases trigger entirely distinct biological responses in the lung tissue.